Allergy Therapeutics cleared by FDA to start testing peanut allergy vaccine
The FDA has cleared Allergy Therapeutics’s application to start a phase I trial with a vaccine for peanut allergies, and the company can now initiate the study in the first half of 2022.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
The race to come first to the billion-dollar food allergy market is heating up.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
